Resistance exercise training and its impact on metabolic syndrome in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
Chaoran Han , Hongyu Xue , Shengtao Yang , Binghong Gao
{"title":"Resistance exercise training and its impact on metabolic syndrome in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials","authors":"Chaoran Han , Hongyu Xue , Shengtao Yang , Binghong Gao","doi":"10.1016/j.diabres.2025.112077","DOIUrl":null,"url":null,"abstract":"<div><div>This <em>meta</em>-analysis investigated the impact of resistance exercise training (RET) on metabolic syndrome (MetS) markers in patients with type 2 diabetes mellitus (T2DM) by synthesizing evidence from randomized controlled trials (RCTs). A systematic search was conducted in four databases up to September 2024. Data were analyzed using random-effects models to calculate mean differences (MD) and 95 % confidence intervals (CI). Fifty RCTs involving 2271 participants (1186 in the intervention group, 1085 in the control group) were included. RET significantly improved key MetS markers, including reductions in fasting blood glucose (MD = −7.09 mg/dl; p < 0.00001), triglyceride (MD = −14.05 mg/dl; p < 0.0001), systolic (MD: −4.13 mmHg; p = 0.0004) and diastolic (MD: −2.03 mmHg; p = 0.02) blood pressure, and waist circumference (MD = −2.18 cm; p < 0.00001). Additionally, RET was associated with increased high-density lipoprotein levels (MD: 1.86 mg/dl; p = 0.002). Subgroup analyses indicated consistent benefits across varing intervention durations and participant genders, underscoring the broad applicability of RET for diverse T2DM populations. These findings suggest that RET is an effective intervention for improving MetS markers in individuals with T2DM. However, limitations such as high heterogeneity and small sample sizes may affect generalizability.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"222 ","pages":"Article 112077"},"PeriodicalIF":6.1000,"publicationDate":"2025-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725000919","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
This meta-analysis investigated the impact of resistance exercise training (RET) on metabolic syndrome (MetS) markers in patients with type 2 diabetes mellitus (T2DM) by synthesizing evidence from randomized controlled trials (RCTs). A systematic search was conducted in four databases up to September 2024. Data were analyzed using random-effects models to calculate mean differences (MD) and 95 % confidence intervals (CI). Fifty RCTs involving 2271 participants (1186 in the intervention group, 1085 in the control group) were included. RET significantly improved key MetS markers, including reductions in fasting blood glucose (MD = −7.09 mg/dl; p < 0.00001), triglyceride (MD = −14.05 mg/dl; p < 0.0001), systolic (MD: −4.13 mmHg; p = 0.0004) and diastolic (MD: −2.03 mmHg; p = 0.02) blood pressure, and waist circumference (MD = −2.18 cm; p < 0.00001). Additionally, RET was associated with increased high-density lipoprotein levels (MD: 1.86 mg/dl; p = 0.002). Subgroup analyses indicated consistent benefits across varing intervention durations and participant genders, underscoring the broad applicability of RET for diverse T2DM populations. These findings suggest that RET is an effective intervention for improving MetS markers in individuals with T2DM. However, limitations such as high heterogeneity and small sample sizes may affect generalizability.
期刊介绍:
Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.